Medical Writing Medical Education Patient education in clinical trials and throughout the product lifecycle

Volume 25, Issue 4 - Medical Education

Patient education in clinical trials and throughout the product lifecycle


Good patient education supports improved outcomes and an efficient, cost-effective healthcare system. In the highly regulated, fast-paced pharmaceutical industry, the challenges that medical writers face in writing for patients are multi-fold. Patient education can be confusing given the wealth of new technologies in healthcare communications, combined with patients being more involved in decisions about their health, and different national and international guidelines and legislations to be adhered to. Furthermore, writers face complexities of trying to meet the needs of diverse populations of patients and specific individuals. In this article, we discuss the importance of effective patient education activities for specific phases of the product lifecycle (from clinical trial participation through to prescribed medicines) and of the patient journey (from disease awareness and diagnosis through to living with long-term chronic illness). The considerations and constraints of developing educational content for patients, and practical guidance for writing such materials are discussed.

Download the full article


  1. Macquart de Terline D, Hejblum G, Fernandez C, Cohen A, Antignac M. PLoS One. 2016;11(1):e0146927.
  2. Feudtner C. What are the goals of patient education? West J Med. 2001;174:173-4.
  3. Adams RJ. Improving health outcomes with better patient understanding and education. Risk Manag Health Policy. 2010;3:61-72.
  4. Hoving C, Visser A, Mullen PD, van den Borne B. A history of patient education by health professionals in Europe and North America: from authority to shared decision making education. Patient Educ Couns. 2010;78(3):275-81.
  5. Powell J, Inglis N, Ronnie J, Large S. The characteristics and motivations of online health information seekers: cross-sectional survey and qualitative interview study. J Med Internet Res. 2011;13(1):e20.
  6. Anderson CM. Information therapy: a prescription for the digital era. Health Care Manag (Frederick). 2013;32(3):242-5.
  7. Hawkins RP, Kreuter M, Resnicow K, Fishbein M, Dijkstra A. Understanding tailoring in communicating about health. Health Educ Res. 2008;23(3):454-66.
  8. Salita JT. Writing for lay audiences: a challenge for scientists. Medical Writing. 2015;24(4):183-9.
  9. Gul R B, Ali PA. Clinical trials: the challenge of recruitment and retention of participants. J Clin Nurs. 2010;19 (1-2):227-33.
  10. Kaur G, Smyth RL, Williamson P. Developing a survey of barriers and facilitators to recruitment in randomized controlled trials. Trials. 2012;13:218.
  11. Brandberg Y, Johansson H, Bergenmar M. Patients’ knowledge and perceived understanding – associations with consenting to participated in cancer clinical trials. Contemp Clin Trials Comm. 2016;2:6-11.
  12. The Center for Information and Study on Clinical Research Participation (CISCRP). Perceptions and Insights Study: Report on ineligible participants and those who terminate participation early. 2013. Available from:
  13. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) E6 Good Clinical Practice: Consolidated guidance. 1996. Available from:
  14. The World Medical Association. Declaration of Helsinki. 2013 [cited 1 Oct 2016]. Available from:
  15. Council for International Organizations of Medical Sciences (CIOMS). International ethical guidelines for biomedical research involving human subjects. 2002. Available from:
  16. Council for International Organizations of Medical Sciences (CIOMS). Final draft CIOMS guidelines. Version 10. September 2015. Available from:
  17. Cartmell KB, Bonilha HS, Matson T, Bryant DC, Zapka J, Bentz TA, et al. Patient participation in cancer clinical trials: a pilot test of lay navigation. Contemp Clin Trials Comm. 2016;3:86-93.
  18. Siegal G, Bonnie RJ, Appelbaum PS. Personalized disclosure by information-ondemand: attending to patients’ needs in the informed consent process. J Law Med Ethics. 2012;40(2):359-67.
  19. US Food and Drug Administration (FDA). Use of electronic informed consent in clinical investigations. Draft guidance. March 2015. Available from:
  20. European Parliament. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC. Available from:
  21. Gillow CL. Layperson summaries of clinical trial results: useful resources in the vacuum of regulatory guidance. Medical Writing. 2015;24(4):205-9.
  22. Robben S, van Kempen J, Heinen M, Zuidema S, Olde RIkkert M, Schers H, et al. Preferences for receiving information among frail older adults and their informal caregivers: a qualitative study. Fam Pract. 2012;29(6):742-7.
  23. Hirsch O, Keller H, Krones T, Donner- Banzhoff N. arriba-lib: evaluation of an electronic library of decision aids in primary care physicians. BMC Med Inform Decis Mak. 2012 Jun 6;12:48.
  24. European Patients’ Forum. Patient Empowerment Campaign. 2015 [cited 1 Oct 2016]. Available from:
  25. European Patients’ Forum. Improving the sustainability of healthcare systems through better adherence to therapies: a multistakeholder approach. Background briefing. 2011 [cited 1 Oct 2016]. Available from:–joint-briefing-paper.pdf
  26. Miller TA. Health literacy and adherence to medical treatment in chronic and acute illness: a meta-analysis. Patient Educ Couns. 2016;99(7):1079-86.
  27. Matsumaya RK, Kuhn LA, Molisani A, Wilson-Genderson MC. Cancer patients’ information needs the first nine months after diagnosis. Patient Educ Couns. 2013;90(1):96-102.
  28. Prochaska JO, DiClemente CC. Stages and processes of self-change in smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390–5.
  29. Prochaska JO. Assessing how people change. Cancer. 1991;67(3 Suppl):805-7.
  30. Medicines and Healthcare Products Regulatory Agency (MHRA). Disease Awareness Campaign Guidelines: Appendix 7. 2012 Jul. Available from:
  31. The Association of the British Pharmaceutical Industry (ABPI). Guidance notes for patient safety and pharmacovigilance in patient support programmes. 2011 [cited 1 Oct 2016]. Available from:
  32. U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. Simply put – a guide for creating easy to understand materials. 2010. Available from:
  33. Dale E. Audiovisual Methods in Teaching. 3rd ed. New York: Holt, Rinehart & Winston; 1969:108.
  34. Giuse NB, Koonce TY, Storrow AB, Kusnoor SV, Ye F. Using health literacy and learning style preferences to optimise the delivery of health information. J Health Commun. 2012;17(Suppl 3): 122-40.
  35. Walsh E, Sheridan A. Factors affecting patient participation in clinical trials in Ireland: a narrative review. Contemp Clin Trials Comm. 2016;3:23-31.
  36. US Food and Drug Administration (FDA). Recruiting Study Subjects – Information Sheet: Guidance for Institutional Review Boards and Clinical Investigators. 2016 [cited 1 Oct 2016]. Available from:
  37. World Self-Medication Industry (WSMI). Advertising of non-prescription medicines to the public. 2008. Available from:



Medical Education
President's Message
Writing for mixed-media training programmes
Lessons from building an accredited medical conference: Design and delivery
Medical education in a medcomms agency
Patient education in clinical trials and throughout the product lifecycle
Writing, publishing, and disseminating a medical review
CME in the Deutsches Ärzteblatt and the development of multiple choice questions for medical educational purposes
Covering a medical advisory board meeting and creating the report or publication: The role of the professional medical writer
Peer review fraud
News from the EMA
Journal Watch
In The Bookstores
The Webscout
Good Writing Practice
Medical Communications
Getting Your Foot in the Door
Profile: An Interview with the organisers of the first Internship Forum
Out on Our Own


The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Editoral Board


Raquel Billiones


Evguenia Alechine

Jonathan Pitt

Managing Editor

Victoria White

Deputy Managing Editor

Alicia Brooks Waltman

Associate Editors

Anuradha Alahari

Jennifer Bell

Nicole Bezuidenhout

Claire Chang

Barbara Grossman

Sarah Milner

John Plant

Sampoorna Rappaz

Amy Whereat

Section Editors

Daniela Kamir


Jennifer Bell


Nicole Bezuidenhout 

Digital Communication

Somsuvro Basu

EMWA News 

Ana Sofia Correia 

Gained in Translation

Ivana Turek

Getting Your Foot in the Door

Wendy Kingdom / Amy Whereat

Good Writing Practice

Alison McIntosh 

In the Bookstores

Maria Kołtowska-Häggström

Lingua Franca and Beyond

Maddy Dyer


Lisa Chamberlain-James

Medical Communications/Writing for Patients

Payal Bhatia

Medical Devices

Evguenia Alechine

My First Medical Writing

Anuradha Alahari

News from the EMA

Adriana Rocha


Tiziana von Bruchhausen


Clare ChangZuo Yen Lee 

Regulatory Matters

Sam Hamilton

Regulatory Public Disclosure

Claire Gudex

Teaching Medical Writing

Louisa Ludwig-Begall / Sarah Kabani

The Crofter: Sustainable Communications

Louisa Marcombes

Veterinary Writing

Editors Emeritus

Elise Langdon-Neuner

Phil Leventhal

Layout Designer

Chris Monk